The GPCR heterotetramer: challenging classical pharmacology

Sergi Ferré

doi:10.1016/j.tips.2015.01.002

journal article Mar 01, 2015

The GPCR heterotetramer: challenging classical pharmacology

Sergi Ferré

Trends in Pharmacological Sciences Vol. 36 No. 3 pp. 145-152 · Elsevier BV

View at Publisher Save 10.1016/j.tips.2015.01.002

Topics

No keywords indexed for this article. Browse by subject →

References

57

[1]

Gilman "G proteins: transducers of receptor-generated signals" Annu. Rev. Biochem. (1987) 10.1146/annurev.bi.56.070187.003151

[2]

Cabrera-Vera "Insights into G protein structure, function and regulation" Endocr. Rev. (2003) 10.1210/er.2000-0026

[3]

Levitzki "G-protein subunit dissociation is not an integral part of G-protein action" Chembiochem (2002) 10.1002/1439-7633(20020902)3:9<815::aid-cbic815>3.0.co;2-e

[4]

Sadana "Physiological roles for G protein-regulated adenylyl cyclase isoforms: insights from knockout and overexpression studies" Neurosignals (2009) 10.1159/000166277

[5]

Dessauer "Identification of a Gialpha binding site on type V adenylyl cyclase" J. Biol. Chem. (1998) 10.1074/jbc.273.40.25831

[6]

Sadana "N terminus of type 5 adenylyl cyclase scaffolds Gs heterotrimer" Mol. Pharmacol. (2009) 10.1124/mol.109.058370

[7]

Neubig "Membrane organization in G-protein mechanisms" FASEB J. (1994) 10.1096/fasebj.8.12.8088459

[8]

Tolkovsky "Mode of coupling between the beta-adrenergic receptor and adenylate cyclase in turkey erythrocytes" Biochemistry (1978) 10.1021/bi00611a020

[9]

Tolkovsky "Coupling of a single adenylate cyclase to two receptors: adenosine and catecholamine" Biochemistry (1979) 10.1021/bi00611a021

[10]

Braun "Adenosine receptor permanently coupled to turkey erythrocyte adenylate cyclase" Biochemistry (1979) 10.1021/bi00577a045

[11]

Gross "Mechanism of activation of A2 adenosine receptors. II. A restricted collision-coupling model of receptor–effector interaction" Mol. Pharmacol. (1991) 10.1016/s0026-895x(25)11018-3

[12]

Nanoff "The A2 adenosine receptor: guanine nucleotide modulation of agonist binding is enhanced by proteolysis" Mol. Pharmacol. (1991) 10.1016/s0026-895x(25)10955-3

[13]

The Fluid Mosaic Model of the Structure of Cell Membranes

S. J. Singer, Garth L. Nicolson

Science 1972 10.1126/science.175.4023.720

[14]

Pike "The challenge of lipid rafts" J. Lipid Res. (2009) 10.1194/jlr.r800040-jlr200

[15]

Cooper "Higher-order organization and regulation of adenylyl cyclases" Trends Pharmacol. Sci. (2006) 10.1016/j.tips.2006.06.002

[16]

Allen "Lipid raft microdomains and neurotransmitter signalling" Nat. Rev. Neurosci. (2007) 10.1038/nrn2059

[17]

Patel "G-protein-coupled receptor-signaling components in membrane raft and caveolae microdomains" Handb. Exp. Pharmacol. (2008) 10.1007/978-3-540-72843-6_7

[18]

Slepak "Mechanism of light-induced translocation of arrestin and transducin in photoreceptors: interaction-restricted diffusion" IUBMB Life (2008) 10.1002/iub.7

[19]

Rosenzweig "Subunit dissociation and diffusion determine the subcellular localization of rod and cone transducins" J. Neurosci. (2007) 10.1523/jneurosci.1421-07.2007

[20]

Nobles "Heterotrimeric G proteins precouple with G protein-coupled receptors in living cells" Proc. Natl. Acad. Sci. U.S.A. (2005) 10.1073/pnas.0504778102

[21]

Galés "Probing the activation-promoted structural rearrangements in preassembled receptor–G protein complexes" Nat. Struct. Mol. Biol. (2006) 10.1038/nsmb1134

[22]

Hein "Gs activation is time-limiting in initiating receptor-mediated signaling" J. Biol. Chem. (2006) 10.1074/jbc.m606713200

[23]

Klein "Signal transduction by a nondissociable heterotrimeric yeast G protein" Proc. Natl. Acad. Sci. U.S.A. (2000) 10.1073/pnas.97.7.3219

[24]

Rebois "Heterotrimeric G proteins form stable complexes with adenylyl cyclase and Kir3.1 channels in living cells" J. Cell Sci. (2006) 10.1242/jcs.03021

[25]

A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor.

A. De Lean, J.M. Stadel, R.J. Lefkowitz

Journal of Biological Chemistry 1980 10.1016/s0021-9258(20)79672-9

[26]

Ferré "G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives" Pharmacol. Rev. (2014) 10.1124/pr.113.008052

[27]

A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein

Matthew R. Whorton, Michael P. Bokoch, Søren G. F. Rasmussen et al.

Proceedings of the National Academy of Sciences 2007 10.1073/pnas.0611448104

[28]

Bayburt "Transducin activation by nanoscale lipid bilayers containing one and two rhodopsins" J. Biol. Chem. (2007) 10.1074/jbc.m701433200

[29]

Ernst "Monomeric G protein-coupled receptor rhodopsin in solution activates its G protein transducin at the diffusion limit" Proc. Natl. Acad. Sci. U.S.A. (2007) 10.1073/pnas.0701967104

[30]

Kuszak "Purification and functional reconstitution of monomeric mu-opioid receptors: allosteric modulation of agonist binding by Gi2" J. Biol. Chem. (2009) 10.1074/jbc.m109.026922

[31]

Redka "Efficacy as an intrinsic property of the M(2) muscarinic receptor in its tetrameric state" Biochemistry (2013) 10.1021/bi4003869

[32]

Redka "Coupling of g proteins to reconstituted monomers and tetramers of the M2 muscarinic receptor" J. Biol. Chem. (2014) 10.1074/jbc.m114.559294

[33]

Calebiro "Single-molecule analysis of fluorescently labeled G-protein-coupled receptors reveals complexes with distinct dynamics and organization" Proc. Natl. Acad. Sci. U.S.A. (2013) 10.1073/pnas.1205798110

[34]

Herrick-Davis "Fluorescence correlation spectroscopy analysis of serotonin, adrenergic, muscarinic, and dopamine receptor dimerization: the oligomer number puzzle" Mol. Pharmacol. (2013) 10.1124/mol.113.087072

[35]

Jastrzebska "GPCR: G protein complexes – the fundamental signaling assembly" Amino Acids (2013) 10.1007/s00726-013-1593-y

[36]

Patowary "The muscarinic M3 acetylcholine receptor exists as two differently sized complexes at the plasma membrane" Biochem. J. (2013) 10.1042/bj20121902

[37]

Heterotrimeric G protein activation by G-protein-coupled receptors

William M. Oldham, Heidi E. Hamm

Nature Reviews Molecular Cell Biology 2008 10.1038/nrm2299

[38]

Crystal structure of the β2 adrenergic receptor–Gs protein complex

Søren G. F. Rasmussen, Brian T. DeVree, Yaozhong Zou et al.

Nature 2011 10.1038/nature10361

[39]

Jastrzebska "Asymmetry of the rhodopsin dimer in complex with transducin" FASEB J. (2013) 10.1096/fj.12-225383

[40]

Lane "A new mechanism of allostery in a G protein-coupled receptor dimer" Nat. Chem. Biol. (2014) 10.1038/nchembio.1593

[41]

Khelashvili "CR-OKB: the G Protein Coupled Receptor Oligomer Knowledge Base" Bioinformatics (2010) 10.1093/bioinformatics/btq264

[42]

Building a new conceptual framework for receptor heteromers

Sergi Ferré, Ruben Baler, Michel Bouvier et al.

Nature Methods 2009 10.1038/nchembio0309-131

[43]

Kenakin "Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery" Pharmacol. Rev. (2010) 10.1124/pr.108.000992

[44]

Ferré "Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes" Proc. Natl. Acad. Sci. U.S.A. (1991) 10.1073/pnas.88.16.7238

[45]

Azdad "Dopamine D2 and adenosine A2A receptors regulate NMDA-mediated excitation in accumbens neurons through A2A-D2 receptor heteromerization" Neuropsychopharmacology (2009) 10.1038/npp.2008.144

[46]

Trifilieff "Detection of antigen interactions ex vivo by proximity ligation assay: endogenous dopamine D2–adenosine A2 receptor complexes in the striatum" Biotechniques (2011) 10.2144/000113719

[47]

Ferré "Adenosine A(2A) receptors and A(2A) receptor heteromers as key players in striatal function" Front. Neuroanat. (2011) 10.3389/fnana.2011.00036

[48]

Armentero "Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease" Pharmacol. Ther. (2011) 10.1016/j.pharmthera.2011.07.004

[49]

Jorg "The dopamine D2 and adenosine A2A receptors: past, present and future trends for the treatment of Parkinson's disease" Curr. Med. Chem. (2014) 10.2174/1389200215666140217110716

[50]

Orru "Striatal pre- and postsynaptic profile of adenosine A(2A) receptor antagonists" PLoS ONE (2011) 10.1371/journal.pone.0016088

Showing 50 of 57 references

Cited By

109

DIMERBOW: exploring possible GPCR dimer interfaces

Adrian García-Recio, Gemma Navarro · 2020

Bioinformatics

Revealing G‐protein‐coupled receptor oligomerization at the single‐molecule level through a nanoscopic lens: methods, dynamics and biological function

Marco Scarselli, Paolo Annibale · 2015

The FEBS Journal

Disruption of Rhodopsin Dimerization with Synthetic Peptides Targeting an Interaction Interface

Beata Jastrzebska, Yuanyuan Chen · 2015

Journal of Biological Chemistry

Metrics

109

Citations

57

References

Details

Published: Mar 01, 2015
Vol/Issue: 36(3)
Pages: 145-152
License: View

Authors

S

Sergi Ferré

Cite This Article

Sergi Ferré (2015). The GPCR heterotetramer: challenging classical pharmacology. Trends in Pharmacological Sciences, 36(3), 145-152. https://doi.org/10.1016/j.tips.2015.01.002

The GPCR heterotetramer: challenging classical pharmacology

You May Also Like